Afarin Reza, Behdarvand Tahereh, Shakerian Elham, Salehipour Bavarsad Samaneh, Rashidi Mojtaba
Cellular and Molecular Research Center, Medical Basic Sciences Research Institute, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Department of Clinical Biochemistry, Faculty of Medicine, Jundishapour University of Medical Sciences, Ahvaz, Iran.
Iran J Basic Med Sci. 2022 Dec;25(12):1498-1503. doi: 10.22038/IJBMS.2022.66802.14649.
Activated cells which are called star-shaped cells, are some of the key factors in the development of liver fibrosis. Activation of NADPH oxidase (NOX) is associated with increased HSCs activity and progression of hepatic fibrosis. In this study, the effects of human exosomes derived from WJ-MSCs on NOX1, NOX2, and NOX4 gene expression in TGF-β-induced hepatic fibrosis were investigated.
LX2 cell line was treated with 2 ng/ml TGF-β for 24 hr, in order to induce liver fibrosis after starvation. In the next step, the cells were treated with several concentrations of the exosomes derived from WJ-MSCs (10, 20, 30, 40, and 50 μg/ml). Finally, Smad3C phosphorylated protein expression level and NOX1, NOX2, and NOX4 gene expression levels were measured.
The results demonstrated that the level of NOX1, NOX2, and NOX4 mRNA expressions decreased significantly during 24 hrs at concentrations of 40 and 50 μg/ml of WJ-MSCs exosomes in TGF-β-induced-HSCs. The p-Smad3C proteins were significantly decreased (fold change: 1.83, 0.05) after exposure to WJ-MSC-derived exosomes.
Treatment with exosomes prevents further activation of HSCs by inhibiting the level of Smad3C phosphorylation. The experimental data of our study suggested that in liver fibrosis, the protection of HSCs activation against TGF-β by inhibiting the NOX pathway via human exosomes of WJ-MSCs is extremely important. It needs further research as a treatment method.
被称为星形细胞的活化细胞是肝纤维化发展的一些关键因素。NADPH氧化酶(NOX)的激活与肝星状细胞(HSCs)活性增加及肝纤维化进展相关。本研究调查了来源于脐带间充质干细胞(WJ-MSCs)的人外泌体对转化生长因子-β(TGF-β)诱导的肝纤维化中NOX1、NOX2和NOX4基因表达的影响。
将LX2细胞系用2 ng/ml TGF-β处理24小时,以便在饥饿后诱导肝纤维化。下一步,用几种浓度(10、20、30、40和50 μg/ml)的来源于WJ-MSCs的外泌体处理细胞。最后,检测Smad3C磷酸化蛋白表达水平以及NOX1、NOX2和NOX4基因表达水平。
结果表明,在TGF-β诱导的HSCs中,当WJ-MSCs外泌体浓度为40和50 μg/ml时,24小时内NOX1、NOX2和NOX4 mRNA表达水平显著降低。暴露于WJ-MSC来源的外泌体后,p-Smad3C蛋白显著降低(倍数变化:1.83,0.05)。
外泌体治疗通过抑制Smad3C磷酸化水平来防止HSCs进一步活化。我们研究的实验数据表明,在肝纤维化中,通过WJ-MSCs的人外泌体抑制NOX途径来保护HSCs免受TGF-β激活极其重要。作为一种治疗方法,这需要进一步研究。